In Fig. 1, a conceptual diagnostic workflow illustrates the potential of APLP1+ brain-derived EVs (BDEVs) in the blood for diagnosing neurodegenerative diseases, presented as an example within a spectrum of brain diseases including brain tumors. This evidence concerns the gene APLP1 and neurodegenerative disease.